DXCM Q2 2020 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$452M+34.3% YoY

Gross Profit

$284M62.9% margin

Operating Income

$68M15.0% margin

Net Income

$46M10.2% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+11.5%

Cash Flow

Operating Cash Flow

$154M

Free Cash Flow

$96M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$2.2B

Stockholders' Equity

$1.4B

Cash & Equivalents

$530M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$452M	$336M	+34.3%
Gross Profit	$284M	$207M	+37.6%
Operating Income	$68M	-$800,000	+8575.0%
Net Income	$46M	-$11M	+541.0%

Geographic Segments

UNITED STATES

$367M81%

Non-US

$85M19%